Abstract

Troponin T is a central component of the thin filament-associated troponin-tropomyosin system and plays an essential role in the Ca(2+) regulation of striated muscle contraction. The importance of the structure and function of troponin T is evident in the regulated isoform expression during development and the point mutations resulting in familial hypertrophic and dilated cardiomyopathies. We report here that turkeys with inherited dilated cardiomyopathy and heart failure express an unusual low molecular weight cardiac troponin T missing 11 amino acids due to the splice out of the normally conserved exon 8-encoded segment. The deletion of a 9-bp segment from intron 7 of the turkey cardiac troponin T gene may be responsible for the weakened splicing of the downstream exon 8 during mRNA processing. The exclusion of the exon 8-encoded segment results in conformational changes in cardiac troponin T, an altered binding affinity for troponin I and tropomyosin, and an increased calcium sensitivity of the actomyosin ATPase. Expression of the exon 8-deleted cardiac troponin T prior to the development of cardiomyopathy in turkeys indicates a novel RNA splicing disease and provides evidence for the role of troponin T structure-function variation in myocardial pathogenesis and heart failure.

Highlights

  • In vertebrate striated muscle, actomyosin ATPase-based contraction is regulated by Ca2ϩ through the thin filamentassociated troponin (Tn)-tropomyosin (Tm) system [1,2,3]

  • Sequencing analysis revealed that the primary structure of the low molecular weight turkey cTnT differs from the wild type (WT) by an unusual exclusion of the segment encoded by exon 8 (⌬E8) (Fig. 2A)

  • Expression of the cloned cDNAs in E. coli yielded proteins that are recognized by the anti-cTnT monoclonal antibody (mAb) CT3 with sizes identical to that of the cTnT variants found in turkey cardiac muscle (Fig. 2B)

Read more

Summary

The abbreviations used are

Troponin; BSA, bovine serum albumin; cTnT, cardiac troponin T; DCM, dilated cardiomyopathy; ⌬E8, exclusion of exon 8; ELISA, enzyme-linked immunosorbent assay; mAb, monoclonal antibody; PIPES, 1,4-piperazinediethanesulfonic acid; PMSF, phenylmethylsulfonyl fluoride; PVA, polyvinyl alcohol; S1, myosin subfragment 1; Tm, tropomyosin; TnC, troponin C; TnI, troponin I; TnT, troponin T; WT, wild type. To explore the structure-function relationship of the NH2terminal domain of TnT, we have shown previously [23,24,25] that the structure of the alternatively spliced NH2-terminal region may modulate the overall conformation of TnT, causing changes in the binding affinity for Tm, TnI, and TnC This mechanism may form the foundation for the physiological and pathological significance of the various TnT isoform expressions in the heart. This finding demonstrates a novel RNA splicing disease and provides evidence for the role of TnT structurefunction relationship in the pathogenesis of DCM and heart failure

EXPERIEMNTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call